Variable | Cutoff level | Number | Survival rates (%) | p-value | |
---|---|---|---|---|---|
3 year | 5 year | ||||
Age (year) | 0.012 | ||||
< 60 | 107 | 43.2 | 39.0 | ||
≥ 60 | 85 | 25.5 | 15.3 | ||
Sex | 0.805 | ||||
Male | 66 | 34.9 | 24.4 | ||
Female | 126 | 35.9 | 29.7 | ||
Jaundice | < 0.001 | ||||
Present | 47 | 6.0 | 6.0 | ||
Absent | 145 | 42.9 | 36.0 | ||
Associated gallstone | 0.577 | ||||
Present | 106 | 35.3 | 25.8 | ||
Absent | 86 | 35.3 | 30.9 | ||
Curability | < 0.001 | ||||
Curative | 163 | 40.4 | 32.1 | ||
Non-curative | 29 | 7.9 | 7.9 | ||
Tumor location | < 0.001 | ||||
Gallbladder neck | 54 | 12.7 | 9.5 | ||
Gallbladder body/fundus | 138 | 44.0 | 35.9 | ||
pT (TNM) | < 0.001 | ||||
pT1 and 2 | 95 | 57.4 | 49.5 | ||
pT3 and 4 | 97 | 12.8 | 6.4 | ||
Lymph node metastasis | < 0.001 | ||||
Negative | 90 | 55.1 | 43.5 | ||
Positive | 102 | 17.5 | 14.6 | ||
Histologic differentiation | 0.154 | ||||
Well/Moderate | 161 | 36.0 | 30.8 | ||
Poor | 31 | 32.1 | 11.5 | ||
Hepatic invasion | < 0.001 | ||||
Present | 90 | 14.2 | 6.7 | ||
Absent | 102 | 53.1 | 45.9 | ||
CRAO | < 0.001 | ||||
Present | 15 | 0.0 | 0.0 | ||
Absent | 177 | 36.0 | 28.7 | ||
Combined portal vein/hepatic artery resection | 0.041 | ||||
Present | 5 | 0.0 | 0.0 | ||
Absent | 187 | 37.8 | 30.1 | ||
Intraoperative blood infusion | 0.011 | ||||
Present | 44 | 16.6 | 5.5 | ||
Absent | 148 | 41.1 | 35.2 | ||
Adjuvant therapy | 0.782 | ||||
Yes | 28 | 31.6 | 13.2 | ||
No | 164 | 35.8 | 30.4 | ||
Overall | 192 | 35.3 | 28.1 |